TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ZVRA

Zevra Therapeutics Inc.

Healthcare · Biotechnology

11.80$ +0.3% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Zevra Therapeutics Inc. (ZVRA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 90.8% of the shares are freely tradable; institutional investors hold 71.8%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 71.8%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.3%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 90.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 9.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 59Mio.

Largest Shareholders

Institutions

Institutions ZVRA
Name Stake (%) Shares Change (%) Date
BlackRock Inc 7.50 4,456,476 -1.1 03/31/2026
Woodline Partners LP 5.81 3,450,943 +0.0 03/31/2026
FMR Inc 5.41 3,211,877 +34.2 03/31/2026
Nantahala Capital Management, LLC 4.25 2,521,936 +42.3 03/31/2026
Vanguard Capital Management, LLC 4.16 2,469,328 +0.0 03/31/2026
State Street Corp 2.63 1,561,569 +5.3 03/31/2026
Geode Capital Management, LLC 2.31 1,371,857 +2.2 03/31/2026

Funds

Funds ZVRA
Name Stake (%) Shares Change (%) Date
Fidelity Contrafund 4.95 2,940,762 -0.1 07/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 3.20 1,899,706 +0.0 07/31/2026
iShares Russell 2000 ETF 2.53 1,501,641 -0.6 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings ZVRA
Person Role Shares Value As of Type
Thompson Rahsaan Chief Legal & Compliance 37,569 443,314 $ Aug 14, 2026 direct
Watton Corey Michael Director 1,800 21,240 $ Aug 10, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 14, 2026 Thompson Rahsaan Chief Legal & Compliance Sell 42,666 11.13 474,774
Aug 10, 2026 Watton Corey Michael Director Sell 12,300 11.25 138,377
Aug 10, 2026 Watton Corey Michael Director Other 12,300 4.97 61,131

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?